Success Stories: A Research Associate Achieves NIW and EB1A Cases Approval with the Help of Our Assistance, Now Awaits I-485 Approval

 

Client’s Testimonial:

“Oh my god. This is great news. Thank you so much. I had the pleasure of working with you too :) I can not thank you enough for making my dream come true. I am very much satisfied with Chen Immigration.”


On December 1st, 2021 and August 29th, 2022, we received another EB2-NIW (National Interest Waiver) and EB-1A (Alien of Extraordinary Ability) approval for a Research Associate in the Field of Neuroscience (Approval Notice).


General Field: Neuroscience

Position at the Time of Case Filing: Research Associate

Country of Origin: India

State of Residence at the Time of Filing: Virginia

Approval Notice Date: December 1st, 2021 (NIW) and August 29th, 2022 (EB-1A)

Processing Time: 10 months, 3 days (NIW) and 1 month, 3 days (EB-1A) (Premium Processing Requested)


Case Summary:

A research associate contacted our law firm to help her establish her significant contributions to the U.S. by filing for an EB-2 NIW (National Interest Waiver) petition. It’s a part of our job to evaluate our client’s qualifications and research background to certify the veracity of her credentials. She even retained our services to construct another petition under the EB-1A (Alien of Extraordinary Ability) visa category.

Her research has generated meaningful insights into the biological mechanism of spermidine’s beneficial contribution to hindering age-related memory loss, introducing the novel approach of using spermidine as a pharmacological intervention. These findings are especially significant considering that age-induced cognitive disorders are increasing as the global population ages.

Therefore, we presented her exceptional professional background and unparalleled experience important to her current and future work at the USCIS:

  • Our client has completed her Ph.D. in genetics and has extensive experience in discovering the cellular and molecular mechanisms of memory function.
  • She has accomplished an excellent publication record in her field. Her work has resulted in 7 peer-reviewed scientific articles.
  • She has conducted at least 10 reviews for at least 3 journals.
  • According to Google Scholar, her work has been cited a total of 785 times in at least 48 countries, and
  • She has even applied for a U.S. patent application based on her work on rhodiola as a treatment for preventing age-related memory impairment.
Furthermore, her study has received funding from at least 18 sources including the German Research Foundation, the European Union, the Netherlands Organization for Scientific Research, the German Federal Ministry of Education and Research, the Austrian Science Fund, and the German Center for Neurodegenerative Diseases. This funding supports projects that promote health and prevent disease, including brain and nervous system disorders.

Her case was further supported by including four recommendation letters that she obtained from her fellow experts in the field. One of the recommenders stated:

“...her ongoing research improves the field’s understanding of memory formation processes, enabling researchers in the United States to target specific metabolic pathways that help in optimizing cognitive disorder treatment plans. Considering the importance of this research, I recommend that [client] be allowed to continue performing her influential research on energy metabolite acetyl-coA production in the United States.”

Our team’s efforts successfully paid off in conveying to the USCIS that our client’s expansive experience in the field of neuroscience has afforded her vast knowledge and formidable skills.

We would like to congratulate her on securing both the I-140 approvals and thanks to the Premium Processing service upgrade for her EB1A case, which was adjudicated in just 1 month, and 3 days. We would also thank her for retaining us for her I-485 application, and we wish her to receive her green card as soon as possible.